Sodium-glucose cotransporter 2 (SGLT2) inhibitors and risk of dementia in people with type 2 diabetes (T2D): A populationbased cohort study

被引：0
|
作者：
Tang, Huilin [1 ]
Shaaban, C. Elizabeth [2 ]
Wu, Yonghui [1 ]
Magoc, Tanja [1 ]
Donahoo, William Troy [1 ]
DeKosky, Steven [1 ]
Bian, Jiang [1 ]
Guo, Serena Jingchuan [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
803
引用
收藏
页码：376 / 376
页数：1
相关论文
共 50 条
  • [31] Sodium-glucose cotransporter 2 inhibitors for people without diabetes
    Fryml, Elise
    Lanktree, Matthew B.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (34) : E1159 - E1160
  • [32] SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS AND REDUCED RISK OF LIVER CANCER IN PEOPLE WITH TYPE 2 DIABETES: A POPULATION-BASED COHORT STUDY
    Huang, Pin-Chia
    Ma, Kevin Sheng-Kai
    HEPATOLOGY, 2023, 78 : S1925 - S1926
  • [33] THE RENOPROTECTIVE EFFECT OF SODIUM-GLUCOSE COTRANSPORTER2 (SGLT2) INHIBITOR DAPAGLIFLOZIN IN TYPE 1 DIABETES
    Hodrea, Judit
    Lenart, Lilla
    Koszegi, Sandor
    Gellai, Renata
    Balogh, Dora B.
    Vannay, Adam
    Wagner, Laszlo J.
    Szabo, Attila J.
    Fekete, Andrea
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1633 - 1634
  • [34] Pharmacoeconomic evaluation of sodium-glucose transporter-2 (SGLT2) inhibitors for the treatment of type 2 diabetes
    Rahman, Wedad
    Solinsky, Paul Joseph
    Munir, Kashif M.
    Lamos, Elizabeth M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (02) : 151 - 161
  • [35] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus
    Mahling, Moritz
    Schork, Anja
    Nadalin, Silvio
    Fritsche, Andreas
    Heyne, Nils
    Guthoff, Martina
    KIDNEY & BLOOD PRESSURE RESEARCH, 2019, 44 (05): : 984 - 992
  • [36] Sodium-glucose cotransporter-2 inhibitors (SGLT2) in frail or older people with type 2 diabetes and heart failure: a systematic review and meta-analysis
    Aldafas, Rami
    Crabtree, Tomas
    Alkharaiji, Mohammed
    Vinogradova, Yana
    Idris, Iskandar
    AGE AND AGEING, 2024, 53 (01)
  • [37] Correlation between the utilization of sodium-glucose cotransporter-2 (SGLT2) inhibitors and the risk of dementia: a nationwide population-based study in Taiwan
    Wu-Lung Chuang
    Stella Chin-Shaw Tsai
    Yi-Chun Yang
    Tsai-Ling Hsieh
    Heng-Jun Lin
    Yu-Han Huang
    Fuu-Jen Tsai
    Kuang-Hsi Chang
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2025, 398 (5) : 5835 - 5843
  • [38] Safety and efficacy of sodium-glucose cotransporter 2 (SGLT2) inhibitors in type 1 diabetes: A systematic review and meta-analysis
    El Masri, Dana
    Ghosh, Samiran
    Jaber, Linda A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 137 : 83 - 92
  • [39] Sodium-glucose cotransporter-2 inhibitors use and risk of dementia in different ethnoracial groups with type 2 diabetes
    Yang, Shih-Chi
    Liao, Wen-Chieh
    Jhang, Yi-Sheng
    Chang, Hui-Chin
    Su, Yu-Jung
    Chen, Shiu-Jau
    Gau, Shuo-Yan
    ALZHEIMERS & DEMENTIA, 2025, 21 (01)
  • [40] Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of AKI in Older Adults with Type 2 Diabetes
    Zhuo, Min
    Paik, Julie M.
    Wexler, Deborah J.
    Bonventre, Joseph V.
    Kim, Seoyoung C.
    Patorno, Elisabetta
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 132 - 133
12345